Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Return on Capital Employed (2017 - 2025)

Historic Return on Capital Employed for Collegium Pharmaceutical (COLL) over the last 9 years, with Q3 2025 value amounting to 0.14%.

  • Collegium Pharmaceutical's Return on Capital Employed fell 800.0% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year decrease of 800.0%. This contributed to the annual value of 0.19% for FY2024, which is 500.0% down from last year.
  • As of Q3 2025, Collegium Pharmaceutical's Return on Capital Employed stood at 0.14%, which was down 800.0% from 0.11% recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Return on Capital Employed ranged from a high of 0.33% in Q2 2024 and a low of 0.02% during Q1 2022
  • Its 5-year average for Return on Capital Employed is 0.13%, with a median of 0.14% in 2025.
  • Per our database at Business Quant, Collegium Pharmaceutical's Return on Capital Employed skyrocketed by 2100bps in 2021 and then tumbled by -2100bps in 2025.
  • Quarter analysis of 5 years shows Collegium Pharmaceutical's Return on Capital Employed stood at 0.04% in 2021, then increased by 10bps to 0.04% in 2022, then skyrocketed by 438bps to 0.24% in 2023, then tumbled by -37bps to 0.15% in 2024, then fell by -8bps to 0.14% in 2025.
  • Its Return on Capital Employed stands at 0.14% for Q3 2025, versus 0.11% for Q2 2025 and 0.12% for Q1 2025.